262 related articles for article (PubMed ID: 22913807)
41. Association between IL28B rs12979860 single nucleotide polymorphism and the frequency of colonic Treg in chronically HCV-infected patients.
Mehta M; Hetta HF; Abdel-Hameed EA; Rouster SD; Hossain M; Mekky MA; Khalil NK; Mohamed WA; El-Feky MA; Ahmed SH; Daef EA; El-Mokhtar MA; Abdelwahab SF; Medhat A; Sherman KE; Shata MT
Arch Virol; 2016 Nov; 161(11):3161-9. PubMed ID: 27544760
[TBL] [Abstract][Full Text] [Related]
42. IFN-λ gene polymorphisms as predictive factors in chronic hepatitis C treatment-naive patients without access to protease inhibitors.
Olmedo DB; Cader SA; Porto LC
J Med Virol; 2015 Oct; 87(10):1702-15. PubMed ID: 25970604
[TBL] [Abstract][Full Text] [Related]
43. HCV RNA decline in chronic HCV genotype 2 and 3 during standard of care treatment according to IL28B polymorphism.
Stenkvist J; Sönnerborg A; Weiland O
J Viral Hepat; 2013 Mar; 20(3):193-9. PubMed ID: 23383658
[TBL] [Abstract][Full Text] [Related]
44. A genetic variant in the interleukin 28B gene as a major predictor for sustained virologic response in chronic hepatitis C virus infection.
Sixtos-Alonso MS; Avalos-Martinez R; Sandoval-Salas R; Dehesa-Violante M; García-Juarez I; Chávez-Ayala A; Domínguez-López A; Vargas-Vorácková F; Toapanta-Yanchapaxi L; Amezcua-Guerra LM; Uribe M; Sánchez-Ávila JF
Arch Med Res; 2015 Aug; 46(6):448-53. PubMed ID: 26189761
[TBL] [Abstract][Full Text] [Related]
45. Assessment of IL-28: rs12979860 and rs8099917 Polymorphisms in a Cohort of Cuban Chronic HCV Genotype 1b Patients.
Palenzuela Gardón D; Guillen IA; Fernández JR; Camacho H; Estevez ZC; Dueñas S; Alvares-Lajonchere L; Amador Y; Martinez-Donato G; Han J; Zhang Z; Zhang X; Gao Y; Campaña JR; Novoa LI
J Biomol Tech; 2017 Jul; 28(2):80-86. PubMed ID: 28058039
[TBL] [Abstract][Full Text] [Related]
46. Impact of the peginterferon-α 2a and ribavirin plasma levels on viral kinetics and sustained virological response in genotype 1 HCV/HIV-co-infected patients with the unfavourable non-CC IL28B genotypes.
Torres-Cornejo A; Ruiz-Valderas R; Jimenez-Jimenez L; Abad-Molina C; Gutierrez-Valencia A; Viciana P; Lopez-Cortes LF
J Viral Hepat; 2014 Mar; 21(3):178-88. PubMed ID: 24438679
[TBL] [Abstract][Full Text] [Related]
47. Low-density lipoprotein receptor genotyping enhances the predictive value of IL28B genotype in HIV/hepatitis C virus-coinfected patients.
Pineda JA; Caruz A; Di Lello FA; Camacho A; Mesa P; Neukam K; Rivero-juárez A; Macías J; Gómez-Mateos J; Rivero A
AIDS; 2011 Jul; 25(11):1415-20. PubMed ID: 21572301
[TBL] [Abstract][Full Text] [Related]
48. Role of IL28B and inosine triphosphatase polymorphisms in the treatment of chronic hepatitis C virus genotype 6 infection.
Seto WK; Tsang OT; Liu K; Chan JM; Wong DK; Fung J; Lai CL; Yuen MF
J Viral Hepat; 2013 Jul; 20(7):470-7. PubMed ID: 23730840
[TBL] [Abstract][Full Text] [Related]
49. Predictive value of interferon-lambda gene polymorphisms for treatment response in chronic hepatitis C.
Susser S; Herrmann E; Lange C; Hamdi N; Müller T; Berg T; Perner D; Zeuzem S; Sarrazin C
PLoS One; 2014; 9(11):e112592. PubMed ID: 25393304
[TBL] [Abstract][Full Text] [Related]
50. IL28B genetic variation and treatment response in patients with hepatitis C virus genotype 3 infection.
Moghaddam A; Melum E; Reinton N; Ring-Larsen H; Verbaan H; Bjøro K; Dalgard O
Hepatology; 2011 Mar; 53(3):746-54. PubMed ID: 21374656
[TBL] [Abstract][Full Text] [Related]
51. High hepatitis B virus surface antigen levels and favorable interleukin 28B genotype predict spontaneous hepatitis C virus clearance in uremic patients.
Yu ML; Dai CY; Huang CF; Lee JJ; Yeh ML; Yeh SM; Kuo HT; Huang JF; Chang JM; Chen HC; Juo SH; Hwang SJ; Chuang WL;
J Hepatol; 2014 Feb; 60(2):253-9. PubMed ID: 24096049
[TBL] [Abstract][Full Text] [Related]
52. Interleukin 28B polymorphism predicts pegylated interferon plus ribavirin treatment outcome in chronic hepatitis C genotype 4.
De Nicola S; Aghemo A; Rumi MG; Galmozzi E; Valenti L; Soffredini R; De Francesco R; Prati GM; D'Ambrosio R; Cheroni C; Donato MF; Colombo M
Hepatology; 2012 Feb; 55(2):336-42. PubMed ID: 21932415
[TBL] [Abstract][Full Text] [Related]
53. Single nucleotide polymorphisms of the IL28B and sustained virologic response of patients with chronic hepatitis C to PEG-interferon/ribavirin therapy: A meta-analysis: Meta-analysis of IL28B.
Li S; Hu P; Zhang QQ; Liu YH; Hu HD; Zhang DZ; Ren H
Hepat Mon; 2011 Mar; 11(3):163-72. PubMed ID: 22087138
[TBL] [Abstract][Full Text] [Related]
54. Serum level of IP-10 increases predictive value of IL28B polymorphisms for spontaneous clearance of acute HCV infection.
Beinhardt S; Aberle JH; Strasser M; Dulic-Lakovic E; Maieron A; Kreil A; Rutter K; Staettermayer AF; Datz C; Scherzer TM; Strassl R; Bischof M; Stauber R; Bodlaj G; Laferl H; Holzmann H; Steindl-Munda P; Ferenci P; Hofer H
Gastroenterology; 2012 Jan; 142(1):78-85.e2. PubMed ID: 22192885
[TBL] [Abstract][Full Text] [Related]
55. Sustained virologic response and IL28B single-nucleotide polymorphisms in patients with chronic hepatitis C treated with pegylated interferon alfa and ribavirin.
Jabłonowska E; Piekarska A; Koślińska-Berkan E; Omulecka A; Szymańska B; Wójcik K
Acta Biochim Pol; 2012; 59(3):333-7. PubMed ID: 22924160
[TBL] [Abstract][Full Text] [Related]
56. Influence of interleukin-28B single-nucleotide polymorphisms on progression to liver cirrhosis in human immunodeficiency virus-hepatitis C virus-coinfected patients receiving antiretroviral therapy.
Barreiro P; Pineda JA; Rallón N; Naggie S; Martín-Carbonero L; Neukam K; Rivero A; Benito JM; Caruz A; Vispo E; Camacho A; Medrano J; McHutchison J; Soriano V
J Infect Dis; 2011 Jun; 203(11):1629-36. PubMed ID: 21592993
[TBL] [Abstract][Full Text] [Related]
57. Interleukin-28B single nucleotide polymorphism of donors and recipients can predict viral response to pegylated interferon/ribavirin therapy in patients with recurrent hepatitis C after living donor liver transplantation.
Kawaoka T; Takahashi S; Takaki S; Hiramatsu A; Waki K; Hiraga N; Miki D; Tsuge M; Imamura M; Kawakami Y; Aikata H; Ochi H; Onoe T; Tashiro H; Ohdan H; Chayama K
J Gastroenterol Hepatol; 2012 Sep; 27(9):1467-72. PubMed ID: 22432893
[TBL] [Abstract][Full Text] [Related]
58. Favourable IFNL3 genotypes are associated with spontaneous clearance and are differentially distributed in Aboriginals in Canadian HIV-hepatitis C co-infected individuals.
Moqueet N; Infante-Rivard C; Platt RW; Young J; Cooper C; Hull M; Walmsley S; Klein MB;
Int J Mol Sci; 2015 Mar; 16(3):6496-512. PubMed ID: 25803108
[TBL] [Abstract][Full Text] [Related]
59. Distribution of IL28B and IL10 polymorphisms as genetic predictors of treatment response in Pakistani HCV genotype 3 patients.
Naeemi H; Aslam R; Raza SM; Shahzad MA; Naz S; Manzoor S; Khaliq S
Arch Virol; 2018 Apr; 163(4):997-1008. PubMed ID: 29340806
[TBL] [Abstract][Full Text] [Related]
60. Interleukin-28B rs12979860C/T and rs8099917T/G contribute to spontaneous clearance of hepatitis C virus in Caucasians.
Zheng MH; Li Y; Xiao DD; Shi KQ; Fan YC; Chen LL; Liu WY; Luo YW; Chen YP
Gene; 2013 Apr; 518(2):479-82. PubMed ID: 23266640
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
